Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

BRIEF-Québec To Acquire 12 Elekta Versa HD Linear Accelerators To Meet Growing Need For Advanced Cancer Care

Published 2020-02-11, 11:41 a/m
Updated 2020-02-11, 01:04 p/m
BRIEF-Québec To Acquire 12 Elekta Versa HD Linear Accelerators To Meet Growing Need For Advanced Cancer Care

Feb 11 (Reuters) - Elekta AB (publ) EKTAb.ST :

* QUÉBEC TO ACQUIRE 12 ELEKTA VERSA HD LINEAR ACCELERATORS TO MEET GROWING NEED FOR ADVANCED CANCER CARE

* ORDER FOR 12 VERSA HD™ LINEAR ACCELERATORS (LINACS) OVER NEXT FIVE YEARS FOR AN ORDER VALUE OF APPROXIMATELY CAD 38.5 MILLION (SEK 275 MILLION)

* QUÉBEC GOVERNMENT'S PROCUREMENT AGENCY FOR MEDICAL TECHNOLOGIES, GROUPE D'APPROVISIONNEMENT COMMUN DE L'EST DU QUÉBEC AWARDED ELEKTA

* CAD 16 MILLION WILL BE BOOKED IN Q4 OF ELEKTA'S FISCAL YEAR 2019/20

* ELEKTA WON CONTRACT THROUGH A PUBLIC PROCUREMENT PROCEDURE, SUBJECT TO A 14-DAY APPEAL

* ORDER IS IN ADDITION TO SIX VERSA HD LINACS PREVIOUSLY BOOKED IN Q2 OF ELEKTA'S FISCAL YEAR 2019/20

* IN THIS FISCAL YEAR, GACEQ HAS AWARDED ELEKTA A TOTAL ORDER VALUE OF APPROXIMATELY CAD 56 MILLION (SEK 407 MILLION)

* FIRST DELIVERIES ARE SCHEDULED FOR Q1 OF ELEKTA'S FISCAL YEAR 2020/21

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.